These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6306393)

  • 21. Recombinant cholera toxin B subunit (rCTB) as a mucosal adjuvant enhances induction of diphtheria and tetanus antitoxin antibodies in mice by intranasal administration with diphtheria-pertussis-tetanus (DPT) combination vaccine.
    Isaka M; Komiya T; Takahashi M; Yasuda Y; Taniguchi T; Zhao Y; Matano K; Matsui H; Maeyama J; Morokuma K; Ohkuma K; Goto N; Tochikubo K
    Vaccine; 2004 Aug; 22(23-24):3061-8. PubMed ID: 15297056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune responses to pertussis vaccines concurrently administered with viral vaccines.
    Halperin SA; Eastwood BJ; Langley JM
    Ann N Y Acad Sci; 1995 May; 754():89-96. PubMed ID: 7625684
    [No Abstract]   [Full Text] [Related]  

  • 23. Mitochondrial swelling induced by diphtheria toxin in vivo: a comparison with the action of some other bacterial toxins.
    Paradisi F
    Experientia; 1967 Dec; 23(12):1045-7. PubMed ID: 4865128
    [No Abstract]   [Full Text] [Related]  

  • 24. Bacterial ADP-ribosylating toxins: form, function, and recombinant vaccine development.
    Burnette WN
    Behring Inst Mitt; 1997 Feb; (98):434-41. PubMed ID: 9382767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acellular pertussis vaccine given by accelerated schedule: response of preterm infants.
    Slack MH; Schapira D; Thwaites RJ; Schapira C; Bamber J; Burrage M; Southern J; Andrews N; Miller E
    Arch Dis Child Fetal Neonatal Ed; 2004 Jan; 89(1):F57-60. PubMed ID: 14711858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The potential of adjuvants to improve immune responses against TdaP vaccines: A preclinical evaluation of MF59 and monophosphoryl lipid A.
    Agnolon V; Bruno C; Leuzzi R; Galletti B; D'Oro U; Pizza M; Seubert A; O'Hagan DT; Baudner BC
    Int J Pharm; 2015 Aug; 492(1-2):169-76. PubMed ID: 26149936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Testing for neutralising potential of serum antibodies to tetanus and diphtheria toxin.
    Sesardic D; Corbel MJ
    Lancet; 1992 Sep; 340(8821):737-8. PubMed ID: 1355844
    [No Abstract]   [Full Text] [Related]  

  • 28. The diphtheria and pertussis components of diphtheria-tetanus toxoids-pertussis vaccine should be genetically inactivated mutant toxins.
    Robbins JB; Schneerson R; Trollfors B; Sato H; Sato Y; Rappuoli R; Keith JM
    J Infect Dis; 2005 Jan; 191(1):81-8. PubMed ID: 15593007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Recent advances in the molecular mechanism of action of bacterial toxins, in particular of diphtheria, cholera, coli, botulinum and shigella toxins as well as tetanospasmin and the toxins of staphylococcus aureus].
    Kolb E
    Z Gesamte Inn Med; 1984 Mar; 39(6):85-92. PubMed ID: 6375175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody microarrays for native toxin detection.
    Rucker VC; Havenstrite KL; Herr AE
    Anal Biochem; 2005 Apr; 339(2):262-70. PubMed ID: 15797567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A cellular pertussis vaccine (Infanrix-DTPa; SB-3). A review of its immunogenicity, protective efficacy and tolerability in the prevention of Bordetella pertussis infection.
    Patel SS; Wagstaff AJ
    Drugs; 1996 Aug; 52(2):254-75. PubMed ID: 8841742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.
    Silfverdal SA; Assudani D; Kuriyakose S; Van Der Meeren O
    Hum Vaccin Immunother; 2014; 10(10):2795-8. PubMed ID: 25483640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toxin interactions with glycoconjugates.
    Wiegandt H
    Adv Cytopharmacol; 1979; 3():17-25. PubMed ID: 382782
    [No Abstract]   [Full Text] [Related]  

  • 34. Acellular vaccines induce cell-mediated immunity to Bordetella pertussis antigens in infants undergoing primary vaccination against pertussis.
    Ausiello CM; Urbani F; La Sala A; Lande R; Piscitelli A; Cassone A
    Dev Biol Stand; 1997; 89():315-20. PubMed ID: 9272365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of treatment reduction for childhood acute lymphoblastic leukemia on serum immunoglobulins and antibodies against vaccine-preventable diseases.
    van Tilburg CM; Bierings MB; Berbers GA; Wolfs TF; Pieters R; Bloem AC; Sanders EA
    Pediatr Blood Cancer; 2012 May; 58(5):701-7. PubMed ID: 21793184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FURTHER OBSERVATIONS ON VACCINATION IN INFANCY WITH ORAL POLIOMYELITIS VACCINE AND DIPHTHERIA, TETANUS, PERTUSSIS VACCINE.
    BUTLER NR; BENSON PF; URQUHART J; GOFFE AP; KNIGHT GJ; POLLOCK TM
    Br Med J; 1964 Aug; 2(5406):418-20. PubMed ID: 14160241
    [No Abstract]   [Full Text] [Related]  

  • 37. Generation of plant-derived recombinant DTP subunit vaccine.
    Brodzik R; Spitsin S; Pogrebnyak N; Bandurska K; Portocarrero C; Andryszak K; Koprowski H; Golovkin M
    Vaccine; 2009 Jun; 27(28):3730-4. PubMed ID: 19464556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group.
    Greco D; Salmaso S; Mastrantonio P; Giuliano M; Tozzi AE; Anemona A; Ciofi degli Atti ML; Giammanco A; Panei P; Blackwelder WC; Klein DL; Wassilak SG
    N Engl J Med; 1996 Feb; 334(6):341-8. PubMed ID: 8538704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model.
    Kwon HJ; Han SB; Kim BR; Kang KR; Huh DH; Choi GS; Ahn DH; Kang JH
    BMC Infect Dis; 2017 Apr; 17(1):247. PubMed ID: 28376777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccines: World Health Organization versus Federal Drug Administration recommended formula.
    Khalil MK; al-Mazrou YY; al-Ghamdi YS
    East Mediterr Health J; 2000 Jul; 6(4):644-51. PubMed ID: 11794070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.